213 related articles for article (PubMed ID: 19249310)
1. Impaired insulin signaling accelerates cardiac mitochondrial dysfunction after myocardial infarction.
Sena S; Hu P; Zhang D; Wang X; Wayment B; Olsen C; Avelar E; Abel ED; Litwin SE
J Mol Cell Cardiol; 2009 Jun; 46(6):910-8. PubMed ID: 19249310
[TBL] [Abstract][Full Text] [Related]
2. Myocardial infarction in rats causes partial impairment in insulin response associated with reduced fatty acid oxidation and mitochondrial gene expression.
Amorim PA; Nguyen TD; Shingu Y; Schwarzer M; Mohr FW; Schrepper A; Doenst T
J Thorac Cardiovasc Surg; 2010 Nov; 140(5):1160-7. PubMed ID: 20850803
[TBL] [Abstract][Full Text] [Related]
3. Genetic loss of insulin receptors worsens cardiac efficiency in diabetes.
Bugger H; Riehle C; Jaishy B; Wende AR; Tuinei J; Chen D; Soto J; Pires KM; Boudina S; Theobald HA; Luptak I; Wayment B; Wang X; Litwin SE; Weimer BC; Abel ED
J Mol Cell Cardiol; 2012 May; 52(5):1019-26. PubMed ID: 22342406
[TBL] [Abstract][Full Text] [Related]
4. Contractile dysfunction in hypertrophied hearts with deficient insulin receptor signaling: possible role of reduced capillary density.
McQueen AP; Zhang D; Hu P; Swenson L; Yang Y; Zaha VG; Hoffman JL; Yun UJ; Chakrabarti G; Wang Z; Albertine KH; Abel ED; Litwin SE
J Mol Cell Cardiol; 2005 Dec; 39(6):882-92. PubMed ID: 16216265
[TBL] [Abstract][Full Text] [Related]
5. Knockout of insulin receptors in cardiomyocytes attenuates coronary arterial dysfunction induced by pressure overload.
Symons JD; Hu P; Yang Y; Wang X; Zhang QJ; Wende AR; Sloan CL; Sena S; Abel ED; Litwin SE
Am J Physiol Heart Circ Physiol; 2011 Jan; 300(1):H374-81. PubMed ID: 20971769
[TBL] [Abstract][Full Text] [Related]
6. Type 1 diabetic cardiomyopathy in the Akita (Ins2WT/C96Y) mouse model is characterized by lipotoxicity and diastolic dysfunction with preserved systolic function.
Basu R; Oudit GY; Wang X; Zhang L; Ussher JR; Lopaschuk GD; Kassiri Z
Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2096-108. PubMed ID: 19801494
[TBL] [Abstract][Full Text] [Related]
7. Contribution of impaired myocardial insulin signaling to mitochondrial dysfunction and oxidative stress in the heart.
Boudina S; Bugger H; Sena S; O'Neill BT; Zaha VG; Ilkun O; Wright JJ; Mazumder PK; Palfreyman E; Tidwell TJ; Theobald H; Khalimonchuk O; Wayment B; Sheng X; Rodnick KJ; Centini R; Chen D; Litwin SE; Weimer BE; Abel ED
Circulation; 2009 Mar; 119(9):1272-83. PubMed ID: 19237663
[TBL] [Abstract][Full Text] [Related]
8. Targeting the glucagon receptor improves cardiac function and enhances insulin sensitivity following a myocardial infarction.
Karwi QG; Zhang L; Wagg CS; Wang W; Ghandi M; Thai D; Yan H; Ussher JR; Oudit GY; Lopaschuk GD
Cardiovasc Diabetol; 2019 Jan; 18(1):1. PubMed ID: 30626440
[TBL] [Abstract][Full Text] [Related]
9. Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression.
Belke DD; Betuing S; Tuttle MJ; Graveleau C; Young ME; Pham M; Zhang D; Cooksey RC; McClain DA; Litwin SE; Taegtmeyer H; Severson D; Kahn CR; Abel ED
J Clin Invest; 2002 Mar; 109(5):629-39. PubMed ID: 11877471
[TBL] [Abstract][Full Text] [Related]
10. Fasting-induced myocardial lipid accumulation in long-chain acyl-CoA dehydrogenase knockout mice is accompanied by impaired left ventricular function.
Bakermans AJ; Geraedts TR; van Weeghel M; Denis S; João Ferraz M; Aerts JM; Aten J; Nicolay K; Houten SM; Prompers JJ
Circ Cardiovasc Imaging; 2011 Sep; 4(5):558-65. PubMed ID: 21737602
[TBL] [Abstract][Full Text] [Related]
11. Cardiac hypertrophy caused by peroxisome proliferator- activated receptor-gamma agonist treatment occurs independently of changes in myocardial insulin signaling.
Sena S; Rasmussen IR; Wende AR; McQueen AP; Theobald HA; Wilde N; Pereira RO; Litwin SE; Berger JP; Abel ED
Endocrinology; 2007 Dec; 148(12):6047-53. PubMed ID: 17823261
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of mitochondrial peroxiredoxin-3 prevents left ventricular remodeling and failure after myocardial infarction in mice.
Matsushima S; Ide T; Yamato M; Matsusaka H; Hattori F; Ikeuchi M; Kubota T; Sunagawa K; Hasegawa Y; Kurihara T; Oikawa S; Kinugawa S; Tsutsui H
Circulation; 2006 Apr; 113(14):1779-86. PubMed ID: 16585391
[TBL] [Abstract][Full Text] [Related]
13. Enhanced acyl-CoA dehydrogenase activity is associated with improved mitochondrial and contractile function in heart failure.
Rennison JH; McElfresh TA; Okere IC; Patel HV; Foster AB; Patel KK; Stoll MS; Minkler PE; Fujioka H; Hoit BD; Young ME; Hoppel CL; Chandler MP
Cardiovasc Res; 2008 Jul; 79(2):331-40. PubMed ID: 18339649
[TBL] [Abstract][Full Text] [Related]
14. Critical role of the NAD(P)H oxidase subunit p47phox for left ventricular remodeling/dysfunction and survival after myocardial infarction.
Doerries C; Grote K; Hilfiker-Kleiner D; Luchtefeld M; Schaefer A; Holland SM; Sorrentino S; Manes C; Schieffer B; Drexler H; Landmesser U
Circ Res; 2007 Mar; 100(6):894-903. PubMed ID: 17332431
[TBL] [Abstract][Full Text] [Related]
15. Time course of changes in the expression of DHPR, RyR(2), and SERCA2 after myocardial infarction in the rat left ventricle.
Sallinen P; Mänttäri S; Leskinen H; Ilves M; Ruskoaho H; Saarela S
Mol Cell Biochem; 2007 Sep; 303(1-2):97-103. PubMed ID: 17516033
[TBL] [Abstract][Full Text] [Related]
16. Optical mapping of propagation changes induced by elevated extracellular potassium ion concentration in genetically altered mouse hearts.
Punske BB; Rossi S; Ershler P; Rasmussen I; Abel ED
J Electrocardiol; 2004; 37 Suppl():128-34. PubMed ID: 15534822
[TBL] [Abstract][Full Text] [Related]
17. Cardiomyocyte-specific overexpression of oestrogen receptor β improves survival and cardiac function after myocardial infarction in female and male mice.
Schuster I; Mahmoodzadeh S; Dworatzek E; Jaisser F; Messaoudi S; Morano I; Regitz-Zagrosek V
Clin Sci (Lond); 2016 Mar; 130(5):365-76. PubMed ID: 26608078
[TBL] [Abstract][Full Text] [Related]
18. Deletion of Tbc1d4/As160 abrogates cardiac glucose uptake and increases myocardial damage after ischemia/reperfusion.
Binsch C; Barbosa DM; Hansen-Dille G; Hubert M; Hodge SM; Kolasa M; Jeruschke K; Weiß J; Springer C; Gorressen S; Fischer JW; Lienhard M; Herwig R; Börno S; Timmermann B; Cremer AL; Backes H; Chadt A; Al-Hasani H
Cardiovasc Diabetol; 2023 Jan; 22(1):17. PubMed ID: 36707786
[TBL] [Abstract][Full Text] [Related]
19. Endothelial nitric oxide synthase limits left ventricular remodeling after myocardial infarction in mice.
Scherrer-Crosbie M; Ullrich R; Bloch KD; Nakajima H; Nasseri B; Aretz HT; Lindsey ML; Vançon AC; Huang PL; Lee RT; Zapol WM; Picard MH
Circulation; 2001 Sep; 104(11):1286-91. PubMed ID: 11551881
[TBL] [Abstract][Full Text] [Related]
20. Adiponectin determines farnesoid X receptor agonism-mediated cardioprotection against post-infarction remodelling and dysfunction.
Xia Y; Zhang F; Zhao S; Li Y; Chen X; Gao E; Xu X; Xiong Z; Zhang X; Zhang J; Zhao H; Wang W; Wang H; Guo Y; Liu Y; Li C; Wang S; Zhang L; Yan W; Tao L
Cardiovasc Res; 2018 Aug; 114(10):1335-1349. PubMed ID: 29668847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
